ES2422885T3 - Vacunación in ovo de campylobacter en especies aviares - Google Patents

Vacunación in ovo de campylobacter en especies aviares Download PDF

Info

Publication number
ES2422885T3
ES2422885T3 ES04798929T ES04798929T ES2422885T3 ES 2422885 T3 ES2422885 T3 ES 2422885T3 ES 04798929 T ES04798929 T ES 04798929T ES 04798929 T ES04798929 T ES 04798929T ES 2422885 T3 ES2422885 T3 ES 2422885T3
Authority
ES
Spain
Prior art keywords
cells
campylobacter
campylobacter jejuni
live
jejuni
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES04798929T
Other languages
English (en)
Spanish (es)
Inventor
Tonia Sue Agin
Everett Lee Rosey
Frederick Henry Weber
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Zoetis P LLC
Original Assignee
Pfizer Products Inc
Zoetis P LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc, Zoetis P LLC filed Critical Pfizer Products Inc
Application granted granted Critical
Publication of ES2422885T3 publication Critical patent/ES2422885T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES04798929T 2003-12-03 2004-11-22 Vacunación in ovo de campylobacter en especies aviares Expired - Lifetime ES2422885T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US52668103P 2003-12-03 2003-12-03
US526681P 2003-12-03
PCT/IB2004/003806 WO2005053737A1 (en) 2003-12-03 2004-11-22 In ovo vaccination of campylobacter in avian species

Publications (1)

Publication Number Publication Date
ES2422885T3 true ES2422885T3 (es) 2013-09-16

Family

ID=34652463

Family Applications (1)

Application Number Title Priority Date Filing Date
ES04798929T Expired - Lifetime ES2422885T3 (es) 2003-12-03 2004-11-22 Vacunación in ovo de campylobacter en especies aviares

Country Status (7)

Country Link
US (2) US8092808B2 (enExample)
EP (1) EP1691831B1 (enExample)
JP (1) JP4602347B2 (enExample)
AU (1) AU2004294810C1 (enExample)
CA (1) CA2547775C (enExample)
ES (1) ES2422885T3 (enExample)
WO (1) WO2005053737A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2561673C2 (ru) 2006-03-30 2015-08-27 Эмбрекс, Инк. Способы и композиции для вакцинации домашней птицы
TWI423814B (zh) * 2006-09-01 2014-01-21 Genticel 用於引發特異性細胞毒性ｔ淋巴細胞（ｃｔｌ）反應之組成物，包含一淋巴去除性化合物以及一含有抗原序列且以專業化抗原呈現細胞為標靶之分子
WO2009012589A1 (en) * 2007-07-23 2009-01-29 University Of Saskatchewan Vaccines and methods for treatment or prevention of gram negative bacterial infection in a vertebrate subject
US10829524B2 (en) * 2014-05-09 2020-11-10 Universiteit Utrecht Holding B.V. CATH2 derivatives
US12194157B2 (en) 2020-04-09 2025-01-14 Finncure Oy Carrier for targeted delivery to a host
AU2021252164A1 (en) 2020-04-09 2022-12-15 Finncure Oy Mimetic nanoparticles for preventing the spreading and lowering the infection rate of novel coronaviruses

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4040388A (en) 1976-02-27 1977-08-09 Agrimatic Corporation Method and apparatus for automatic egg injection
US4593646A (en) 1982-06-01 1986-06-10 Agrimatic Corporation Egg injection method and apparatus
US4469047A (en) 1983-10-25 1984-09-04 Miller Gary E Apparatus and method for injecting eggs
US4681063A (en) 1986-07-02 1987-07-21 Embrex Inc. High speed automated injection system for avian embryos
JPH07206705A (ja) 1993-11-03 1995-08-08 American Cyanamid Co 生インオボ（ｉｎ ｏｖｏ）ワクチン
GB2298432B (en) 1995-03-03 1999-04-14 Orion Yhtymae Oy In ovo administration of a competitive exclusion culture
ES2224273T3 (es) 1996-09-30 2005-03-01 University Of Arkansas Metodo para producir inmunidad activa por medio de un conjugado de vacuna.
BR9809149A (pt) 1997-05-20 2000-08-01 Galenica Pharmaceuticals Inc Análogos de triterpeno saponina dotados de adjuvante e atividade imonoestimulatória
US6048535A (en) 1997-06-12 2000-04-11 Regents Of The University Of Minnesota Multivalent in ovo avian vaccine
US6019985A (en) 1998-02-27 2000-02-01 Munova Corporation Immunostimulation methods for providing disease protection in poultry
US6410222B1 (en) * 1998-12-14 2002-06-25 Juridical Foundation The Chemosero-Therapeutic Research Institute In ovo vaccination of marek's disease type I virus
US20020187162A1 (en) 2001-04-21 2002-12-12 Geary Steven J. Use of a live attenuated Mycoplasma gallisepticum strain as a vaccine and vector for the protection of chickens and turkeys from respiratory disease
DE60114420T2 (de) 2001-10-04 2006-07-13 Centrum Voor Onderzoek In Diergeneeskunde En Agrochemie Abgeschwächter Mutantenstamm eines Virus der Newcastle-Krankheit für eine in Ovo Impfung und dessen Benutzung

Also Published As

Publication number Publication date
AU2004294810B2 (en) 2010-12-16
CA2547775C (en) 2012-01-03
WO2005053737A1 (en) 2005-06-16
US20070116722A1 (en) 2007-05-24
EP1691831A1 (en) 2006-08-23
EP1691831B1 (en) 2013-05-15
CA2547775A1 (en) 2005-06-16
US8092808B2 (en) 2012-01-10
JP4602347B2 (ja) 2010-12-22
AU2004294810C1 (en) 2013-02-14
US8431138B2 (en) 2013-04-30
AU2004294810A1 (en) 2005-06-16
JP2007513138A (ja) 2007-05-24
US20120107351A1 (en) 2012-05-03

Similar Documents

Publication Publication Date Title
Tizard Vaccines for Veterinarians E-Book
JP2640525B2 (ja) 無毒の微生物とその使用
JP5014413B2 (ja) 家禽のワクチン接種のための方法及び組成物
ES2753142T3 (es) Vacuna y métodos para reducir una infección por Campylobacter
US8431138B2 (en) In ovo vaccination of Campylobacter in avian species
JP2004536106A (ja) マイコプラズマ・ボビスワクチンおよび動物の肺炎を減少させる方法
ES2316492T3 (es) Vacuna contra la salmonella.
EA036764B1 (ru) Ослабленный штамм streptococcus suis, индуцирующий иммунный ответ у свиней, и его применение
ES2222152T3 (es) Vacuna con las salmonellas que no inducen anticuerpos que reaccionan con la flagelina o los flagelos.
CN119816588A (zh) 鸡毒支原体活疫苗
ES2824402T3 (es) Vacunas atenuadas contra Pasteurella multocida y procedimientos de fabricación y uso de las mismas
BR112015010364B1 (pt) Vacinas atenuadas de mannheimia haemolytica e métodos de produção e uso
KR100602460B1 (ko) 백신용 약독화 생박테리아
US7807144B2 (en) Oral vaccines
JP4705573B2 (ja) 弱毒細菌生ワクチン
US8628947B2 (en) Potomac horse fever isolates
JP7281208B2 (ja) ＳｓｅＪタンパク質を用いたサルモネラワクチン
KR101950931B1 (ko) ptsI 및 crr 유전자 결손된 약독화 살모넬라 타이피뮤리움 균주 및 상기 균주를 이용한 생균 백신 조성물
KR100358642B1 (ko) 난내생백신
KR20230094420A (ko) 내독성이 감소되고 약독화된 살모넬라 갈리나룸 변이주를 유효성분으로 포함하는 가금티푸스 예방 또는 치료용 백신 조성물
Liu Development and Evaluation of Novel Vaccination Strategies for Campylobacter Control in Poultry
CN113827716A (zh) 犬瘟热病毒弱毒株、及其制备的疫苗组合物和应用
CN1325731A (zh) 用于疫苗的活减毒细菌
BR102019021511A2 (pt) Método de produção de proteínas recombinantes do toxocara canis, visadas como vacina para controle da toxocaríase canina
BR102016016891B1 (pt) Fosfatase ácida recombinante rcp01850 de corynebacterium pseudotuberculosis e seu uso em vacinas de subunidade para a linfadenite caseosa